B50
Conditions
Interventions
Group 1: Patients with confirmed Plasmodium falciparum malaria undergoing outpatient or inpatient treatment are or may be included in the study. The form of treatment and therapy is based on the stand
Sponsors
Charité - Universtitätsmedizin Berlin, Fächerverbund für Infektiologie, Pneumologie und Intensivmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Infection with Plasmodium falciparum
Exclusion criteria
Exclusion criteria: Patient cannot give informed consent due to physical or mental disability age <18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients infected with P. falciparum who are initially treated on an outpatient basis and who receive unscheduled medical care related to malaria or complications of malaria (including treatment complications) during the 28-day follow-up period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of outpatients with at least one complication of malaria infection or malaria treatment during the 28-day follow-up period Proportion of outpatients with at least one hospitalization due to malaria infection or malaria treatment during the 28-day follow-up period Reasons for unplanned hospitalizations/admissions to identify risk factors for failure of outpatient treatment Proportion of patients still alive 28 days after starting treatment (for inpatients and outpatients) Comparison of clinical parameters and outcomes of inpatients with those of outpatients Investigation of clinical criteria relevant for hospital admission of patients with P. falciparum malaria in Europe | — |
Countries
Belgium, Denmark, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
Contacts
Public ContactTilman Lingscheid
Charité - Universtitätsmedizin Berlin, Fächerverbund für Infektiologie, Pneumologie und Intensivmedizin
Outcome results
None listed